AARD NASDAQ
Aardvark Therapeutics, Inc. Common Stock
1W: -66.7%
1M: -75.3%
3M: -75.6%
YTD: -90.1%
1Y: -87.8%
$1.30
+0.22 (+20.37%)
Weekly Expected Move ±33.3%
$0
$1
$1
$2
$2
Credit Risk of going bust: higher than 91% of companies Debt: 2.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99%), Aardvark Therapeutics, Inc. Common Stock would be worth roughly what it owes.
Total debt $677K against a stock market value of $28.5M.
Distance to default 1.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $539K (short-term plus half of long-term), stock volatility 173.6%; Altman Z'' 5.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.02 (down 99%), Aardvark Therapeutics, Inc. Common Stock would be worth roughly what it owes.
Total debt $677K against a stock market value of $28.5M.
Distance to default 1.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $539K (short-term plus half of long-term), stock volatility 173.6%; Altman Z'' 5.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2026-03-24
Earliest Filing
2026-03-24
Latest Filing
partner: 1
Counterparties (Filed by AARD)
1 relationshipsCompanies named in AARD's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-23 | Other Events; Exhibits | View | |
| 2026-10-22 | Other Events; Exhibits | View | |
| 2026-10-08 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-08-17 | Shareholder Vote | View | |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-06-12 | Officer/Director Change; Exhibits | View | |
| 2026-05-14 | Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-24 | Material Agreement; Exhibits | Agreement | View |
| 2026-03-23 | Earnings Release; Exhibits | View | |
| 2026-02-27 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-12 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2026-02-10 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-10 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-06 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-04 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-03 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR